Brielle Benyon

The United States Preventative Services Task Force now recommends colorectal cancer screening to start at 45 years old.

There is no fall risk assessment that is specific to oncology, but one could be helpful in preventing accidents.

While some people face barriers to colorectal cancer screening, at-home fecal immunochemical tests (FIT) can help.

An intervention to decrease chemotherapy wait times led to better patient satisfaction and reduced anxiety.

When in-person classes on central venous catheter care were limited due to the COVID-19 pandemic, educational videos became even more important.

The FDA granted an accelerated approval to pembrolizumab plus trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the frontline treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.

Knowing your patient’s beliefs and goals is key to providing ethical cancer care.

Nurse practitioners are more valuable than ever in the world of cancer care.

It is well known that fear of recurrence is a major issue in the cancer community, but can genetic test results outlining risk impact those feelings?

When patients rely on lip-reading to communicate, mask mandates have major effects on their care.

A recent study analyzed the benefits and work-related stressors of end-of-life care.

Breast cancer survivors may experience an increase in fear of recurrence after undergoing genomic testing that reveals risk.

The current scale often used to measure nurse quality of life may be missing some key factors, according to recent research.

The FDA approved dostarlimab (Jemperli) for the treatment of patients with recurrent or advanced endometrial cancer that progressed on or after platinum-containing chemotherapy and whose cancer is DNA mismatch repair deficient (dMMR), as determined by an FDA-approved test.

Certified nurse specialists play a crucial role in their institutions achieving Disease-Specific Care certifications – which can ultimately improve patient outcomes.

The FDA approved nivolumab (Opdivo) plus certain types of chemotherapy for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction (GEJ) cancer, and esophageal adenocarcinoma.

The FDA granted an accelerated approval to sacituzumab govitecan (Trodelvy) for patients with locally advanced or metastatic urothelial cancer (mUC) who previously had a platinum-containing chemotherapy and a PD-1 or PD-L1 inhibitor.

An Arkansas law may lay the groundwork for unfair care in certain populations, but there are always nurses and other clinicians ready to advocate for all of their patients.

Caregivers have their own set of issues and anxieties, but a telehealth support service may help.

The FDA granted a regular approval to sacituzumab govitecan (Trodelvy) for previously treated patients with unresectable locally advanced or metastatic triple-negative breast cancer.

Wearable fitness trackers may boost fitness, quality of life and overall health in childhood cancer survivors.

Patient-reported outcomes (PRO) hold valuable information on how patients are handling cancer treatment. Recent research analyzed which methods of PROs patients prefer.

In this episode of “The Vitals,” we spoke with Jody Koenig Kellas, PhD, department chair and professor, interpersonal, family, and health communication at the University of Nebraska – Lincoln. Her research looked at the communal cancer experience, and gives clinicians direct tips on how they can reframe hope for patients and caregivers.

While there have been advancements in palliative care programs and clinician education, more still needs to be done, one expert says.

A recent study found that cultural awareness among nurses is not enough. Clinicians need more training and resources to improve cancer care for patients with limited English proficiency.

We want to hear from you: what is the limiting factor in managing adverse events in patients with cancer?

Sleep is key to optimal health, and bright white light therapy may help adolescent cancer survivors improve their circadian rhythms.

Here are the key points to know about the National Comprehensive Cancer Network’s guidelines on treating cancer during the COVID-19 pandemic.

As more Americans get vaccinated against COVID-19, new questions arise, such as: how often should cancer survivors who have been vaccinated against the disease be tested for antibodies?